Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Smith, U
   Pioglitazone: mechanism of action
   INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
   
   U. Smith, "Pioglitazone: mechanism of action", INT J CL PR, 2001, pp. 13-18
2. Kaplan, F; Al-Majali, K; Betteridge, DJ
   PPARs, insulin resistance and type 2 diabetes
   JOURNAL OF CARDIOVASCULAR RISK
   
   F. Kaplan et al., "PPARs, insulin resistance and type 2 diabetes", J CARD RISK, 8(4), 2001, pp. 211-217
3. Scheen, AJ
   Thiazolidinediones and liver toxicity
   DIABETES & METABOLISM
   
   A.J. Scheen, "Thiazolidinediones and liver toxicity", DIABETE MET, 27(3), 2001, pp. 305-313
4. Blickle, JF
   Thiazolidinediones: clinical data and perspectives
   DIABETES & METABOLISM
   
   J.F. Blickle, "Thiazolidinediones: clinical data and perspectives", DIABETE MET, 27(2), 2001, pp. 279-285
5. Halimi, S
   Type 2 diabetes mellitus: Which place for thiazolidinediones in the therapeutic strategy?
   DIABETES & METABOLISM
   
   S. Halimi, "Type 2 diabetes mellitus: Which place for thiazolidinediones in the therapeutic strategy?", DIABETE MET, 27(2), 2001, pp. 287-293
6. Collins, AR; Meehan, WP; Kintscher, U; Jackson, S; Wakino, S; Noh, G; Palinski, W; Hsueh, WA; Law, RE
   Troglitazone inhibits formation of early atherosclerotic lesions in diabetic and nondiabetic low density lipoprotein receptor-deficient mice
   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
   
   A.R. Collins et al., "Troglitazone inhibits formation of early atherosclerotic lesions in diabetic and nondiabetic low density lipoprotein receptor-deficient mice", ART THROM V, 21(3), 2001, pp. 365-371
7. Rosenblatt, S; Miskin, B; Glazer, NB; Prince, MJ; Robertson, KE
   The impact of pioglitazone on glycemic control and atherogenic dyslipidemia in patients with type 2 diabetes mellitus
   CORONARY ARTERY DISEASE
   
   S. Rosenblatt et al., "The impact of pioglitazone on glycemic control and atherogenic dyslipidemia in patients with type 2 diabetes mellitus", CORON ART D, 12(5), 2001, pp. 413-423
8. Sugawara, A; Takeuchi, K; Uruno, A; Ikeda, Y; Arima, S; Sato, K; Kudo, M; Taniyama, Y; Ito, S
   Differential effects among thiazolidinediones on the transcription of thromboxane receptor and angiotensin II type 1 receptor genes
   Hypertension research
   
   A. Sugawara et al., "Differential effects among thiazolidinediones on the transcription of thromboxane receptor and angiotensin II type 1 receptor genes", HYPERTENS R, 24(3), 2001, pp. 229-233
9. Kushibiki, S; Hodate, K; Shingu, H; Ueda, Y; Shinoda, M; Mori, Y; Itoh, T; Yokomizo, Y
   Insulin resistance induced in dairy steers by tumor necrosis factor alpha is partially reversed by 2,4-thiazolidinedione
   DOMESTIC ANIMAL ENDOCRINOLOGY
   
   S. Kushibiki et al., "Insulin resistance induced in dairy steers by tumor necrosis factor alpha is partially reversed by 2,4-thiazolidinedione", DOM ANIM EN, 21(1), 2001, pp. 25-37
10. Perfetti, R; Chamie, K
    Enhancing insulin action: From chemical elements to thiazolidinediones
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
    
    R. Perfetti e K. Chamie, "Enhancing insulin action: From chemical elements to thiazolidinediones", J ENDOC INV, 24(4), 2001, pp. 274-287
11. Yoshida, K; Kohzuki, M; Xu, HL; Wu, XM; Kamimoto, M; Sato, T
    Effects of troglitazone and temocapril in spontaneously hypertensive rats with chronic renal failure
    JOURNAL OF HYPERTENSION
    
    K. Yoshida et al., "Effects of troglitazone and temocapril in spontaneously hypertensive rats with chronic renal failure", J HYPERTENS, 19(3), 2001, pp. 503-510
12. Tsuji, T; Mizushige, K; Noma, T; Murakami, K; Ohmori, K; Miyatake, A; Kohno, M
    Pioglitazone improves left ventricular diastolic function and decreases collagen accumulation in prediabetic stage of a type II diabetic rat
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
    
    T. Tsuji et al., "Pioglitazone improves left ventricular diastolic function and decreases collagen accumulation in prediabetic stage of a type II diabetic rat", J CARDIO PH, 38(6), 2001, pp. 868-874
13. Goetze, S; Kintscher, U; Kim, S; Meehan, WP; Kaneshiro, K; Collins, AR; Fleck, E; Hsueh, WA; Law, RE
    Peroxisome proliferator-activated receptor-gamma ligands inhibit nuclear but not cytosolic extracellular signal-regulated kinase/mitogen-activated protein kinase-regulated steps in vascular smooth muscle cell migration
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
    
    S. Goetze et al., "Peroxisome proliferator-activated receptor-gamma ligands inhibit nuclear but not cytosolic extracellular signal-regulated kinase/mitogen-activated protein kinase-regulated steps in vascular smooth muscle cell migration", J CARDIO PH, 38(6), 2001, pp. 909-921
14. Chilcott, J; Tappenden, P; Jones, ML; Wight, JP
    A systematic review of the clinical effectiveness of pioglitazone in the treatment of type 2 diabetes mellitus
    CLINICAL THERAPEUTICS
    
    J. Chilcott et al., "A systematic review of the clinical effectiveness of pioglitazone in the treatment of type 2 diabetes mellitus", CLIN THER, 23(11), 2001, pp. 1792-1823
15. Kramer, D; Shapiro, R; Adler, A; Bush, E; Rondinone, CM
    Insulin-sensitizing effect of rosiglitazone (BRL-49653) by regulation of glucose transporters in muscle and fat of Zucker rats
    METABOLISM-CLINICAL AND EXPERIMENTAL
    
    D. Kramer et al., "Insulin-sensitizing effect of rosiglitazone (BRL-49653) by regulation of glucose transporters in muscle and fat of Zucker rats", METABOLISM, 50(11), 2001, pp. 1294-1300
16. Bebernitz, GR; Argentieri, G; Battle, B; Brennan, C; Balkan, B; Burkey, BF; Eckhardt, M; Gao, JP; Kapa, P; Strohschein, RJ; Schuster, HF; Wilson, M; Xu, DD
    The effect of 1,3-diaryl-[1H]-pyrazole-4-acetamides on glucose utilizationin ob/ob mice
    JOURNAL OF MEDICINAL CHEMISTRY
    
    G.R. Bebernitz et al., "The effect of 1,3-diaryl-[1H]-pyrazole-4-acetamides on glucose utilizationin ob/ob mice", J MED CHEM, 44(16), 2001, pp. 2601-2611
17. Fukunaga, Y; Itoh, H; Doi, K; Tanaka, T; Yamashita, J; Chun, TH; Inoue, M; Masatsugu, K; Sawada, N; Saito, T; Hosoda, K; Kook, H; Ueda, M; Nakao, K
    Thiazolidinediones, peroxisome proliferator-activated receptor gamma agonists, regulate endothelial cell growth and secretion of vasoactive peptides
    ATHEROSCLEROSIS
    
    Y. Fukunaga et al., "Thiazolidinediones, peroxisome proliferator-activated receptor gamma agonists, regulate endothelial cell growth and secretion of vasoactive peptides", ATHEROSCLER, 158(1), 2001, pp. 113-119
18. Janka, HU
    Glitazone - Profile of a new class of substances
    INTERNIST
    
    H.U. Janka, "Glitazone - Profile of a new class of substances", INTERNIST, 42(4), 2001, pp. 587
19. Itami, A; Watanabe, G; Shimada, Y; Hashimoto, Y; Kawamura, J; Kato, M; Hosotani, R; Imamura, M
    Ligands for peroxisome proliferator-activated receptor gamma inhibit growth of pancreatic cancers both in vitro and in vivo
    INTERNATIONAL JOURNAL OF CANCER
    
    A. Itami et al., "Ligands for peroxisome proliferator-activated receptor gamma inhibit growth of pancreatic cancers both in vitro and in vivo", INT J CANC, 94(3), 2001, pp. 370-376
20. Niiya, T; Osawa, H; Onuma, H; Suzuki, Y; Taira, M; Yamada, K; Makino, H
    Activation of mouse phosphodiesterase 3B gene promoter by adipocyte differentiation in 3T3-L1 cells
    FEBS LETTERS
    
    T. Niiya et al., "Activation of mouse phosphodiesterase 3B gene promoter by adipocyte differentiation in 3T3-L1 cells", FEBS LETTER, 505(1), 2001, pp. 136-140
21. Takamura, T; Nohara, E; Nagai, Y; Kobayashi, K
    Stage-specific effects of a thiazolidinedione on proliferation, differentiation and PPAR gamma mRNA expression in 3T3-L1 adipocytes
    EUROPEAN JOURNAL OF PHARMACOLOGY
    
    T. Takamura et al., "Stage-specific effects of a thiazolidinedione on proliferation, differentiation and PPAR gamma mRNA expression in 3T3-L1 adipocytes", EUR J PHARM, 422(1-3), 2001, pp. 23-29
22. Goke, R; Goke, A; Goke, B; El-Deiry, WS; Chen, YH
    Pioglitazone inhibits growth of carcinoid cells and promotes TRAIL-inducedapoptosis by induction of p21(waf1/cip1)
    DIGESTION
    
    R. Goke et al., "Pioglitazone inhibits growth of carcinoid cells and promotes TRAIL-inducedapoptosis by induction of p21(waf1/cip1)", DIGESTION, 64(2), 2001, pp. 75-80
23. Rieusset, J; Chambrier, C; Bouzakri, K; Dusserre, E; Auwerx, J; Riou, JP; Laville, M; Vidal, H
    The expression of the p85 alpha subunit of phosphatidylinositol 3-Kinase is induced by activation of the peroxisome proliferator-activated receptor gamma in human adipocytes
    DIABETOLOGIA
    
    J. Rieusset et al., "The expression of the p85 alpha subunit of phosphatidylinositol 3-Kinase is induced by activation of the peroxisome proliferator-activated receptor gamma in human adipocytes", DIABETOLOG, 44(5), 2001, pp. 544-554
24. Oakes, ND; Thalen, PG; Jacinto, SM; Ljung, B
    Thiazolidinediones increase plasma-adipose tissue FFA exchange capacity and enhance insulin-mediated control of systemic FFA availability
    DIABETES
    
    N.D. Oakes et al., "Thiazolidinediones increase plasma-adipose tissue FFA exchange capacity and enhance insulin-mediated control of systemic FFA availability", DIABETES, 50(5), 2001, pp. 1158-1165
25. Shintani, M; Nishimura, H; Yonemitsu, S; Ogawa, Y; Hayashi, T; Hosoda, K; Inoue, G; Nakao, K
    Troglitazone not only increases GLUT4 but also induces its translocation in rat adipocytes
    DIABETES
    
    M. Shintani et al., "Troglitazone not only increases GLUT4 but also induces its translocation in rat adipocytes", DIABETES, 50(10), 2001, pp. 2296-2300
26. Furuse, Y; Ogino, K; Shimoyama, M; Sasaki, N; Hisatome, I
    Ca2+-sensitizing effect is involved in the positive inotropic effect of troglitazone
    BRITISH JOURNAL OF PHARMACOLOGY
    
    Y. Furuse et al., "Ca2+-sensitizing effect is involved in the positive inotropic effect of troglitazone", BR J PHARM, 133(8), 2001, pp. 1307-1313
27. Klotz, U; Sailer, D
    Drug interactions - their impact on safe drug therapy as exemplified by the novel group of thiazolidinediones (glitazones)
    ARZNEIMITTEL-FORSCHUNG-DRUG RESEARCH
    
    U. Klotz e D. Sailer, "Drug interactions - their impact on safe drug therapy as exemplified by the novel group of thiazolidinediones (glitazones)", ARZNEI-FOR, 51(2), 2001, pp. 112-117
28. Mykkanen, L
    Prevention of coronary heart disease in type 2 diabetes
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
    
    L. Mykkanen, "Prevention of coronary heart disease in type 2 diabetes", INT J CL PR, 2000, pp. 40-45
29. Tan, MH
    Current treatment of insulin resistance in type 2 diabetes mellitus
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
    
    M.H. Tan, "Current treatment of insulin resistance in type 2 diabetes mellitus", INT J CL PR, 2000, pp. 54-62
30. Kawamori, R
    The role of the liver on post-prandial glycaemia - emphasis on hepatic glucose uptake
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
    
    R. Kawamori, "The role of the liver on post-prandial glycaemia - emphasis on hepatic glucose uptake", INT J CL PR, 2000, pp. 19-22
31. Fuchtenbusch, M; Standl, E; Schatz, H
    Clinical efficacy of new thiazolidinediones and glinides in the treatment of type 2 diabetes mellitus
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES
    
    M. Fuchtenbusch et al., "Clinical efficacy of new thiazolidinediones and glinides in the treatment of type 2 diabetes mellitus", EXP CL E D, 108(3), 2000, pp. 151-163
32. Schatz, H; Massi-Benedetti, M
    Pioglitazone: From development to clinical practice
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES
    
    H. Schatz e M. Massi-Benedetti, "Pioglitazone: From development to clinical practice", EXP CL E D, 108, 2000, pp. S221-S223
33. Tan, MH
    How pioglitazone affects glucose and lipid metabolism
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES
    
    M.H. Tan, "How pioglitazone affects glucose and lipid metabolism", EXP CL E D, 108, 2000, pp. S224-S233
34. Eckland, DA; Danhof, M
    Clinical pharmacokinetics of pioglitazone
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES
    
    D.A. Eckland e M. Danhof, "Clinical pharmacokinetics of pioglitazone", EXP CL E D, 108, 2000, pp. S234-S242
35. Buse, JB
    Pioglitazone in the treatment of type 2 diabetes mellitus: US clinical experience
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES
    
    J.B. Buse, "Pioglitazone in the treatment of type 2 diabetes mellitus: US clinical experience", EXP CL E D, 108, 2000, pp. S250-S255
36. Hanefeld, M; Goke, B
    Combining pioglitazone with a sulphonylurea or metformin in the managementof type 2 diabetes
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES
    
    M. Hanefeld e B. Goke, "Combining pioglitazone with a sulphonylurea or metformin in the managementof type 2 diabetes", EXP CL E D, 108, 2000, pp. S256-S266
37. Belcher, G; Matthews, DR
    Safety and tolerability of pioglitazone
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES
    
    G. Belcher e D.R. Matthews, "Safety and tolerability of pioglitazone", EXP CL E D, 108, 2000, pp. S267-S273
38. Kimura, M; Daimon, M; Tominaga, M; Manaka, H; Sasaki, H; Kato, T
    Thiazolidinediones exert different effects on insulin resistance between dexamethasone-treated rats and Wistar fatty rats
    ENDOCRINE JOURNAL
    
    M. Kimura et al., "Thiazolidinediones exert different effects on insulin resistance between dexamethasone-treated rats and Wistar fatty rats", ENDOCR J, 47(1), 2000, pp. 21-28
39. Grinsell, JW; Lardinois, CK; Swislocki, A; Gonzalez, R; Sare, JS; Michaels, JR; Starich, GH
    Pioglitazone attenuates basal and postprandial insulin concentrations and blood pressure in the spontaneously hypertensive rat
    AMERICAN JOURNAL OF HYPERTENSION
    
    J.W. Grinsell et al., "Pioglitazone attenuates basal and postprandial insulin concentrations and blood pressure in the spontaneously hypertensive rat", AM J HYPERT, 13(4), 2000, pp. 370-375
40. Einhorn, D; Rendell, M; Rosenzweig, J; Egan, JW; Mathisen, AL; Schneider, RL
    Pioglitazone hydrochloride in combination with metformin in the treatment of type 2 diabetes melitus: A randomized, placebo-controlled study
    CLINICAL THERAPEUTICS
    
    D. Einhorn et al., "Pioglitazone hydrochloride in combination with metformin in the treatment of type 2 diabetes melitus: A randomized, placebo-controlled study", CLIN THER, 22(12), 2000, pp. 1395-1409
41. Yamazaki, Y; Osaka, T; Murakami, T; Inoue, S
    JTT-501, a new oral hypoglycemic agent, reverses hypertriglyceridemia in Zucker fatty and ventromedial hypothalamus-lesioned obese rats
    METABOLISM-CLINICAL AND EXPERIMENTAL
    
    Y. Yamazaki et al., "JTT-501, a new oral hypoglycemic agent, reverses hypertriglyceridemia in Zucker fatty and ventromedial hypothalamus-lesioned obese rats", METABOLISM, 49(5), 2000, pp. 574-578
42. Suzuki, A; Yasuno, T; Kojo, H; Hirosumi, J; Mutoh, S; Notsu, Y
    Alteration in expression profiles of a series of diabetes-related genes indb/db mice following treatment with thiazolidinediones
    JAPANESE JOURNAL OF PHARMACOLOGY
    
    A. Suzuki et al., "Alteration in expression profiles of a series of diabetes-related genes indb/db mice following treatment with thiazolidinediones", JPN J PHARM, 84(2), 2000, pp. 113-123
43. Katoh, Y; Hashimoto, S; Kimura, J; Watanabe, T
    Inhibitory action of troglitazone, an insulin-sensitizing agent, on the calcium current in cardiac ventricular cells of guinea pig
    JAPANESE JOURNAL OF PHARMACOLOGY
    
    Y. Katoh et al., "Inhibitory action of troglitazone, an insulin-sensitizing agent, on the calcium current in cardiac ventricular cells of guinea pig", JPN J PHARM, 82(2), 2000, pp. 102-109
44. Okura, T; Nakamura, M; Takata, Y; Watanabe, S; Kitami, Y; Hiwada, K
    Troglitazone induces apoptosis via the p53 and Gadd45 pathway in vascular smooth muscle cells
    EUROPEAN JOURNAL OF PHARMACOLOGY
    
    T. Okura et al., "Troglitazone induces apoptosis via the p53 and Gadd45 pathway in vascular smooth muscle cells", EUR J PHARM, 407(3), 2000, pp. 227-235
45. Uchida, K; Ogino, K; Shimoyama, M; Hisatome, I; Shigemasa, C
    Acute hemodynamic effects of insulin-sensitizing agents in isolated perfused rat hearts
    EUROPEAN JOURNAL OF PHARMACOLOGY
    
    K. Uchida et al., "Acute hemodynamic effects of insulin-sensitizing agents in isolated perfused rat hearts", EUR J PHARM, 400(1), 2000, pp. 113-119
46. Gillies, PS; Dunn, CJ
    Pioglitazone
    DRUGS
    
    P.S. Gillies e C.J. Dunn, "Pioglitazone", DRUGS, 60(2), 2000, pp. 333-343
47. Rahbar, S; Natarajan, R; Yerneni, KK; Scott, S; Gonzales, N; Nadler, JL
    Evidence that pioglitazone, metformin and pentoxifylline are inhibitors ofglycation
    CLINICA CHIMICA ACTA
    
    S. Rahbar et al., "Evidence that pioglitazone, metformin and pentoxifylline are inhibitors ofglycation", CLIN CHIM A, 301(1-2), 2000, pp. 65-77
48. Sakamoto, J; Kimura, H; Moriyama, S; Odaka, H; Momose, Y; Sugiyama, Y; Sawada, H
    Activation of human peroxisome proliferator-activated receptor (PPAR) subtypes by pioglitazone
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
    
    J. Sakamoto et al., "Activation of human peroxisome proliferator-activated receptor (PPAR) subtypes by pioglitazone", BIOC BIOP R, 278(3), 2000, pp. 704-711
49. Subramaniam, S
    The emerging role of thiazolidinediones in the treatment of diabetes-mellitus and related disorders
    CLINICAL AND EXPERIMENTAL HYPERTENSION
    
    S. Subramaniam, "The emerging role of thiazolidinediones in the treatment of diabetes-mellitus and related disorders", CLIN EXP HY, 21(1-2), 1999, pp. 121-136
50. Ishikawa, Y; Takeno, H; Watanabe, K; Tani, T
    Lipogenic action of the novel oral antidiabetic agent HQL-975 in genetically obese diabetic KK-Ay mice
    BIOLOGICAL & PHARMACEUTICAL BULLETIN
    
    Y. Ishikawa et al., "Lipogenic action of the novel oral antidiabetic agent HQL-975 in genetically obese diabetic KK-Ay mice", BIOL PHAR B, 22(6), 1999, pp. 572-576
51. Day, C
    Thiazolidinediones: a new class of antidiabetic drugs
    DIABETIC MEDICINE
    
    C. Day, "Thiazolidinediones: a new class of antidiabetic drugs", DIABET MED, 16(3), 1999, pp. 179-192
52. Takamura, T; Ando, H; Nagai, Y; Yamashita, H; Nohara, E; Kobayashi, K
    Pioglitazone prevents mice from multiple low-dose streptozotocin-induced insulitis and diabetes
    DIABETES RESEARCH AND CLINICAL PRACTICE
    
    T. Takamura et al., "Pioglitazone prevents mice from multiple low-dose streptozotocin-induced insulitis and diabetes", DIABET RE C, 44(2), 1999, pp. 107-114
53. Yoshimoto, T; Naruse, M; Shizume, H; Naruse, K; Tanabe, A; Tanaka, M; Tago, K; Irie, K; Muraki, T; Demura, H; Zardi, L
    Vasculo-protective effects of insulin sensitizing agent pioglitazone in neointimal thickening and hypertensive vascular hypertrophy
    ATHEROSCLEROSIS
    
    T. Yoshimoto et al., "Vasculo-protective effects of insulin sensitizing agent pioglitazone in neointimal thickening and hypertensive vascular hypertrophy", ATHEROSCLER, 145(2), 1999, pp. 333-340
54. Sunaga, Y; Inagaki, N; Gonoi, T; Yamada, Y; Ishida, H; Seino, Y; Seino, S
    Troglitazone but not pioglitazone affects ATP-sensitive K+ channel activity
    EUROPEAN JOURNAL OF PHARMACOLOGY
    
    Y. Sunaga et al., "Troglitazone but not pioglitazone affects ATP-sensitive K+ channel activity", EUR J PHARM, 381(1), 1999, pp. 71-76
55. Shibata, T; Matsui, K; Yonemori, F; Wakitani, K
    Triglyceride-lowering effect of a novel insulin-sensitizing agent, JTT-501
    EUROPEAN JOURNAL OF PHARMACOLOGY
    
    T. Shibata et al., "Triglyceride-lowering effect of a novel insulin-sensitizing agent, JTT-501", EUR J PHARM, 373(1), 1999, pp. 85-91
56. Knock, GA; Mishra, SK; Aaronson, PI
    Differential effects of insulin-sensitizers troglitazone and rosiglitazoneon ion currents in rat vascular myocytes
    EUROPEAN JOURNAL OF PHARMACOLOGY
    
    G.A. Knock et al., "Differential effects of insulin-sensitizers troglitazone and rosiglitazoneon ion currents in rat vascular myocytes", EUR J PHARM, 368(1), 1999, pp. 103-109
57. Shibata, T; Matsui, K; Nagao, K; Shinkai, H; Yonemori, F; Wakitani, K
    Pharmacological profiles of a novel oral antidiabetic agent, JTT-501, an isoxazolidinedione derivative
    EUROPEAN JOURNAL OF PHARMACOLOGY
    
    T. Shibata et al., "Pharmacological profiles of a novel oral antidiabetic agent, JTT-501, an isoxazolidinedione derivative", EUR J PHARM, 364(2-3), 1999, pp. 211-219
58. Maegawa, H; Obata, T; Shibata, T; Fujita, T; Ugi, S; Morino, K; Nishio, Y; Kojima, H; Hidaka, H; Haneda, R; Yasuda, H; Kikkawa, R; Kashiwagi, A
    A new antidiabetic agent (JTT-501) rapidly stimulates glucose disposal rates by enhancing insulin signal transduction in skeletal muscle
    DIABETOLOGIA
    
    H. Maegawa et al., "A new antidiabetic agent (JTT-501) rapidly stimulates glucose disposal rates by enhancing insulin signal transduction in skeletal muscle", DIABETOLOG, 42(2), 1999, pp. 151-159
59. Walker, AB; Chattington, PD; Buckingham, RE; Williams, G
    The thiazolidinedione rosiglitazone (BRL-49653) lowers blood pressure and protects against impairment of endothelial function in Zucker fatty rats
    DIABETES
    
    A.B. Walker et al., "The thiazolidinedione rosiglitazone (BRL-49653) lowers blood pressure and protects against impairment of endothelial function in Zucker fatty rats", DIABETES, 48(7), 1999, pp. 1448-1453
60. Shimoyama, M; Ogino, K; Tanaka, Y; Ikeda, T; Hisatome, I
    Hemodynamic basis for the acute cardiac effects of troglitazone in isolated perfused rat hearts
    DIABETES
    
    M. Shimoyama et al., "Hemodynamic basis for the acute cardiac effects of troglitazone in isolated perfused rat hearts", DIABETES, 48(3), 1999, pp. 609-615
61. Asano, M; Nakajima, T; Iwasawa, K; Morita, T; Nakamura, F; Imuta, H; Chisaki, K; Yamada, N; Omata, M; Okuda, Y
    Troglitazone and pioglitazone attenuate agonist-dependent Ca2+ mobilization and cell proliferation in vascular smooth muscle cells
    BRITISH JOURNAL OF PHARMACOLOGY
    
    M. Asano et al., "Troglitazone and pioglitazone attenuate agonist-dependent Ca2+ mobilization and cell proliferation in vascular smooth muscle cells", BR J PHARM, 128(3), 1999, pp. 673-683
62. Paul, M
    Modes of action and clinical efficacy of pioglitazone as a new principle for the treatment of type 2 diabetes
    ARZNEIMITTEL-FORSCHUNG-DRUG RESEARCH
    
    M. Paul, "Modes of action and clinical efficacy of pioglitazone as a new principle for the treatment of type 2 diabetes", ARZNEI-FOR, 49(10), 1999, pp. 835-842
63. FUJISHIMA S; OHYA Y; NAKAMURA Y; ONAKA U; ABE I; FUJISHIMA M
    TROGLITAZONE, AN INSULIN SENSITIZER, INCREASES FOREARM BLOOD-FLOW IN HUMANS
    American journal of hypertension
    
    S. Fujishima et al., "TROGLITAZONE, AN INSULIN SENSITIZER, INCREASES FOREARM BLOOD-FLOW IN HUMANS", American journal of hypertension, 11(9), 1998, pp. 1134-1137
64. PUGAZHENTHI S; KHANDELWAL RL
    INSULIN ACTION ON PROTEIN PHOSPHATASE-1 ACTIVATION IS ENHANCED BY THEANTIDIABETIC AGENT PIOGLITAZONE IN CULTURED DIABETIC HEPATOCYTES
    Molecular and cellular biochemistry
    
    S. Pugazhenthi e R.L. Khandelwal, "INSULIN ACTION ON PROTEIN PHOSPHATASE-1 ACTIVATION IS ENHANCED BY THEANTIDIABETIC AGENT PIOGLITAZONE IN CULTURED DIABETIC HEPATOCYTES", Molecular and cellular biochemistry, 182(1-2), 1998, pp. 185-191
65. GOUD C; PITT B; WEBB RC; RICHEY JM
    SYNERGISTIC ACTIONS OF INSULIN AND TROGLITAZONE ON CONTRACTILITY IN ENDOTHELIUM-DENUDED RAT AORTIC RINGS
    American journal of physiology: endocrinology and metabolism
    
    C. Goud et al., "SYNERGISTIC ACTIONS OF INSULIN AND TROGLITAZONE ON CONTRACTILITY IN ENDOTHELIUM-DENUDED RAT AORTIC RINGS", American journal of physiology: endocrinology and metabolism, 38(5), 1998, pp. 882-887
66. ISHIKAWA Y; SAITO MNI; IKEMOTO T; TAKENO H; WATANABE K; TANI T
    ACTIONS OF THE NOVEL ORAL ANTIDIABETIC AGENT HQL-975 IN INSULIN-RESISTANT NON-INSULIN-DEPENDENT DIABETES-MELLITUS MODEL ANIMALS
    Diabetes research and clinical practice
    
    Y. Ishikawa et al., "ACTIONS OF THE NOVEL ORAL ANTIDIABETIC AGENT HQL-975 IN INSULIN-RESISTANT NON-INSULIN-DEPENDENT DIABETES-MELLITUS MODEL ANIMALS", Diabetes research and clinical practice, 41(2), 1998, pp. 101-111
67. KAWAMORI R; MATSUHISA M; KINOSHITA J; MOCHIZUKI K; NIWA M; ARISAKA T; IKEDA M; KUBOTA M; WADA M; KANDA T; IKEBUCHI M; TOHDA R; YAMASAKI Y
    PIOGLITAZONE ENHANCES SPLANCHNIC GLUCOSE-UPTAKE AS WELL AS PERIPHERALGLUCOSE-UPTAKE IN NON-INSULIN-DEPENDENT DIABETES-MELLITUS
    Diabetes research and clinical practice
    
    R. Kawamori et al., "PIOGLITAZONE ENHANCES SPLANCHNIC GLUCOSE-UPTAKE AS WELL AS PERIPHERALGLUCOSE-UPTAKE IN NON-INSULIN-DEPENDENT DIABETES-MELLITUS", Diabetes research and clinical practice, 41(1), 1998, pp. 35-43
68. VERMA S; BHANOT S; ARIKAWA E; YAO LF; MCNEILL JH
    DIRECT VASODEPRESSOR EFFECTS OF PIOGLITAZONE IN SPONTANEOUSLY HYPERTENSIVE RATS
    Pharmacology
    
    S. Verma et al., "DIRECT VASODEPRESSOR EFFECTS OF PIOGLITAZONE IN SPONTANEOUSLY HYPERTENSIVE RATS", Pharmacology, 56(1), 1998, pp. 7-16
69. SUGIMOTO M; TAKEDA N; NAKASHIMA K; OKUMURA S; TAKAMI K; YOSHINO K; HATTORI J; ISHIMORI M; TAKAMI R; SASAKI A; YASUDA K
    EFFECTS OF TROGLITAZONE ON HEPATIC AND PERIPHERAL INSULIN-RESISTANCE INDUCED BY GROWTH-HORMONE EXCESS IN RATS
    Metabolism, clinical and experimental
    
    M. Sugimoto et al., "EFFECTS OF TROGLITAZONE ON HEPATIC AND PERIPHERAL INSULIN-RESISTANCE INDUCED BY GROWTH-HORMONE EXCESS IN RATS", Metabolism, clinical and experimental, 47(7), 1998, pp. 783-787
70. OKUMURA S; TAKEDA N; TAKAMI K; YOSHINO K; HATTORI J; NAKASHIMA K; SUGIMOTO M; ISHIMORI M; TAKAMI R; YASUDA K
    EFFECTS OF TROGLITAZONE ON DEXAMETHASONE-INDUCED INSULIN-RESISTANCE IN RATS
    Metabolism, clinical and experimental
    
    S. Okumura et al., "EFFECTS OF TROGLITAZONE ON DEXAMETHASONE-INDUCED INSULIN-RESISTANCE IN RATS", Metabolism, clinical and experimental, 47(3), 1998, pp. 351-354
71. Thuillier, P; Baillie, R; Sha, XM; Clarke, SD
    Cytosolic and nuclear distribution of PPAR gamma 2 in differentiating 3T3-L1 preadipocytes
    JOURNAL OF LIPID RESEARCH
    
    P. Thuillier et al., "Cytosolic and nuclear distribution of PPAR gamma 2 in differentiating 3T3-L1 preadipocytes", J LIPID RES, 39(12), 1998, pp. 2329-2338
72. OBATA T; MAEGAWA H; KASHIWAGI A; PILLAY TS; KIKKAWA R
    HIGH GLUCOSE-INDUCED ABNORMAL EPIDERMAL GROWTH-FACTOR SIGNALING
    Journal of Biochemistry
    
    T. Obata et al., "HIGH GLUCOSE-INDUCED ABNORMAL EPIDERMAL GROWTH-FACTOR SIGNALING", Journal of Biochemistry, 123(5), 1998, pp. 813-820
73. KIHARA S; OUCHI N; FUNAHASHI T; SHINOHARA E; TAMURA R; YAMASHITA S; MATSUZAWA Y
    TROGLITAZONE ENHANCES GLUCOSE-UPTAKE AND INHIBITS MITOGEN-ACTIVATED PROTEIN-KINASE IN HUMAN AORTIC SMOOTH-MUSCLE CELLS
    Atherosclerosis
    
    S. Kihara et al., "TROGLITAZONE ENHANCES GLUCOSE-UPTAKE AND INHIBITS MITOGEN-ACTIVATED PROTEIN-KINASE IN HUMAN AORTIC SMOOTH-MUSCLE CELLS", Atherosclerosis, 136(1), 1998, pp. 163-168
74. SHIMAYA A; KUROSAKI E; SHIODUKA K; NAKANO R; SHIBASAKI M; SHIKAMA H
    YM268 INCREASES THE GLUCOSE-UPTAKE, CELL-DIFFERENTIATION, AND MESSENGER-RNA EXPRESSION OF GLUCOSE-TRANSPORTER IN 3T3-L1 ADIPOCYTES
    Hormone and Metabolic Research
    
    A. Shimaya et al., "YM268 INCREASES THE GLUCOSE-UPTAKE, CELL-DIFFERENTIATION, AND MESSENGER-RNA EXPRESSION OF GLUCOSE-TRANSPORTER IN 3T3-L1 ADIPOCYTES", Hormone and Metabolic Research, 30(9), 1998, pp. 543-548
75. IKEDA S; WATANABE T
    EFFECTS OF TROGLITAZONE AND PIOGLITAZONE ON THE ACTION-POTENTIALS ANDMEMBRANE CURRENTS OF RABBIT VENTRICULAR MYOCYTES
    European journal of pharmacology
    
    S. Ikeda e T. Watanabe, "EFFECTS OF TROGLITAZONE AND PIOGLITAZONE ON THE ACTION-POTENTIALS ANDMEMBRANE CURRENTS OF RABBIT VENTRICULAR MYOCYTES", European journal of pharmacology, 357(2-3), 1998, pp. 243-250
76. SU TZ; WANG M; OXENDER DL; SALTIEL AR
    TROGLITAZONE INCREASES SYSTEM-A AMINO-ACID-TRANSPORT IN 3T3-L1 CELLS
    Endocrinology
    
    T.Z. Su et al., "TROGLITAZONE INCREASES SYSTEM-A AMINO-ACID-TRANSPORT IN 3T3-L1 CELLS", Endocrinology, 139(3), 1998, pp. 832-837
77. MURASE K; ODAKA H; SUZUKI M; TAYUKI N; IKEDA H
    PIOGLITAZONE TIME-DEPENDENTLY REDUCES TUMOR-NECROSIS-FACTOR-ALPHA LEVEL IN MUSCLE AND IMPROVES METABOLIC ABNORMALITIES IN WISTAR FATTY RATS
    Diabetologia
    
    K. Murase et al., "PIOGLITAZONE TIME-DEPENDENTLY REDUCES TUMOR-NECROSIS-FACTOR-ALPHA LEVEL IN MUSCLE AND IMPROVES METABOLIC ABNORMALITIES IN WISTAR FATTY RATS", Diabetologia, 41(3), 1998, pp. 257-264
78. WALKER AB; NADERALI EK; CHATTINGTON PD; BUCKINGHAM RE; WILLIAMS G
    DIFFERENTIAL VASOACTIVE EFFECTS OF THE INSULIN SENSITIZERS ROSIGLITAZONE (BRL-49653) AND TROGLITAZONE ON HUMAN SMALL ARTERIES IN-VITRO
    Diabetes
    
    A.B. Walker et al., "DIFFERENTIAL VASOACTIVE EFFECTS OF THE INSULIN SENSITIZERS ROSIGLITAZONE (BRL-49653) AND TROGLITAZONE ON HUMAN SMALL ARTERIES IN-VITRO", Diabetes, 47(5), 1998, pp. 810-814
79. MATSUDA J; HOSODA K; ITOH H; SON C; DOI K; HANAOKA I; INOUE G; NISHIMURA H; YOSHIMASA Y; YAMORI Y; ODAKA H; NAKAO K
    INCREASED ADIPOSE EXPRESSION OF THE UNCOUPLING PROTEIN-3 GENE BY THIAZOLIDINEDIONES IN WISTAR FATTY RATS AND IN CULTURED ADIPOCYTES
    Diabetes
    
    J. Matsuda et al., "INCREASED ADIPOSE EXPRESSION OF THE UNCOUPLING PROTEIN-3 GENE BY THIAZOLIDINEDIONES IN WISTAR FATTY RATS AND IN CULTURED ADIPOCYTES", Diabetes, 47(11), 1998, pp. 1809-1814
80. ARAKAWA K; ISHIHARA T; AOTO M; INAMASU M; SAITO A; IKEZAWA K
    ACTIONS OF NOVEL ANTIDIABETIC THIAZOLIDINEDIONE, T-174, IN ANIMAL-MODELS OF NON-INSULIN-DEPENDENT DIABETES-MELLITUS (NIDDM) AND IN CULTUREDMUSCLE-CELLS
    British Journal of Pharmacology
    
    K. Arakawa et al., "ACTIONS OF NOVEL ANTIDIABETIC THIAZOLIDINEDIONE, T-174, IN ANIMAL-MODELS OF NON-INSULIN-DEPENDENT DIABETES-MELLITUS (NIDDM) AND IN CULTUREDMUSCLE-CELLS", British Journal of Pharmacology, 125(3), 1998, pp. 429-436
81. NAKAMURA Y; OHYA Y; ONAKA U; FUJII K; ABE I; FUJISHIMA M
    INHIBITORY-ACTION OF INSULIN-SENSITIZING AGENTS ON CALCIUM CHANNELS IN SMOOTH-MUSCLE CELLS FROM RESISTANCE ARTERIES OF GUINEA-PIG
    British Journal of Pharmacology
    
    Y. Nakamura et al., "INHIBITORY-ACTION OF INSULIN-SENSITIZING AGENTS ON CALCIUM CHANNELS IN SMOOTH-MUSCLE CELLS FROM RESISTANCE ARTERIES OF GUINEA-PIG", British Journal of Pharmacology, 123(4), 1998, pp. 675-682
82. UEDA N; NOMURA Y; MUTA Y; MATSUZAKI Y; HAYASHIBE M; INO Y; SUZUKI S; KURUMI M
    PHARMACOLOGICAL AND PHARMACOKINETIC STUDIES OF THE NEWLY SYNTHESIZED THIAZOLIDINEDIONE DERIVATIVE ROPANECARBONYLAMINO)BENZYL)-THIAZOLIDINE-2,4-DIONE
    Arzneimittel-Forschung
    
    N. Ueda et al., "PHARMACOLOGICAL AND PHARMACOKINETIC STUDIES OF THE NEWLY SYNTHESIZED THIAZOLIDINEDIONE DERIVATIVE ROPANECARBONYLAMINO)BENZYL)-THIAZOLIDINE-2,4-DIONE", Arzneimittel-Forschung, 48(6), 1998, pp. 651-657
83. ISHIKAWA Y; WATANABE K; TAKENO H; TANI T
    EFFECTS OF THE NOVEL ORAL ANTIDIABETIC AGENT HQL-975 ON GLUCOSE AND LIPID-METABOLISM IN DIABETIC DB DB MICE/
    Arzneimittel-Forschung
    
    Y. Ishikawa et al., "EFFECTS OF THE NOVEL ORAL ANTIDIABETIC AGENT HQL-975 ON GLUCOSE AND LIPID-METABOLISM IN DIABETIC DB DB MICE/", Arzneimittel-Forschung, 48(3), 1998, pp. 245-250
84. NISHIMURA Y; INOUE Y; TAKEUCHI H; OKA Y
    ACUTE EFFECTS OF PIOGLITAZONE ON GLUCOSE-METABOLISM IN PERFUSED-RAT-LIVER
    Acta diabetologica
    
    Y. Nishimura et al., "ACUTE EFFECTS OF PIOGLITAZONE ON GLUCOSE-METABOLISM IN PERFUSED-RAT-LIVER", Acta diabetologica, 34(3), 1997, pp. 206-210
85. KOTCHEN TA; REDDY S; ZHANG HY
    INCREASING INSULIN SENSITIVITY LOWERS BLOOD-PRESSURE IN THE FRUCTOSE-FED RAT
    American journal of hypertension
    
    T.A. Kotchen et al., "INCREASING INSULIN SENSITIVITY LOWERS BLOOD-PRESSURE IN THE FRUCTOSE-FED RAT", American journal of hypertension, 10(9), 1997, pp. 1020-1026
86. SAKU K; ZHANG B; OHTA T; ARAKAWA K
    TROGLITAZONE LOWERS BLOOD-PRESSURE AND ENHANCES INSULIN SENSITIVITY IN WATANABE HERITABLE HYPERLIPIDEMIC RABBITS
    American journal of hypertension
    
    K. Saku et al., "TROGLITAZONE LOWERS BLOOD-PRESSURE AND ENHANCES INSULIN SENSITIVITY IN WATANABE HERITABLE HYPERLIPIDEMIC RABBITS", American journal of hypertension, 10(9), 1997, pp. 1027-1033
87. MORIKANG E; BENSON SC; KURTZ TW; PERSHADSINGH HA
    EFFECTS OF THIAZOLIDINEDIONES ON GROWTH AND DIFFERENTIATION OF HUMAN AORTA AND CORONARY MYOCYTES
    American journal of hypertension
    
    E. Morikang et al., "EFFECTS OF THIAZOLIDINEDIONES ON GROWTH AND DIFFERENTIATION OF HUMAN AORTA AND CORONARY MYOCYTES", American journal of hypertension, 10(4), 1997, pp. 440-446
88. CIARALDI T; HENRY RR
    THIAZOLIDINEDIONES AND THEIR EFFECTS ON GLUCOSE TRANSPORTERS
    European journal of endocrinology
    
    T. Ciaraldi e R.R. Henry, "THIAZOLIDINEDIONES AND THEIR EFFECTS ON GLUCOSE TRANSPORTERS", European journal of endocrinology, 137(6), 1997, pp. 610-612
89. SHIMAYA A; NOSHIRO O; HIRAYAMA R; YONETA T; NIIGATA K; SHIKAMA H
    INSULIN SENSITIZER YM268 AMELIORATES INSULIN-RESISTANCE BY NORMALIZING THE DECREASED CONTENT OF GLUT4 IN ADIPOSE-TISSUE OF OBESE ZUCKER RATS
    European journal of endocrinology
    
    A. Shimaya et al., "INSULIN SENSITIZER YM268 AMELIORATES INSULIN-RESISTANCE BY NORMALIZING THE DECREASED CONTENT OF GLUT4 IN ADIPOSE-TISSUE OF OBESE ZUCKER RATS", European journal of endocrinology, 137(6), 1997, pp. 693-700
90. HUFF BE; LEFFELMAN CL; LETOURNEAU ME; SULLIVAN KA; WARD JA; STILLE JR
    SYNTHETIC APPROACHES TO BENZOFURAN CONTAINING INSULIN SENSITIVITY ENHANCER COMPOUNDS FOR TREATMENT OF TYPE-II DIABETES
    Heterocycles
    
    B.E. Huff et al., "SYNTHETIC APPROACHES TO BENZOFURAN CONTAINING INSULIN SENSITIVITY ENHANCER COMPOUNDS FOR TREATMENT OF TYPE-II DIABETES", Heterocycles, 45(7), 1997, pp. 1363-1384
91. NOSHIRO O; HIRAYAMA R; SHIMAYA A; YONETA T; NIIGATA K; SHIKAMA H
    ROLE OF PLASMA-INSULIN CONCENTRATION IN REGULATING GLUCOSE AND LIPID-METABOLISM IN LEAN AND OBESE ZUCKER RATS
    International journal of obesity
    
    O. Noshiro et al., "ROLE OF PLASMA-INSULIN CONCENTRATION IN REGULATING GLUCOSE AND LIPID-METABOLISM IN LEAN AND OBESE ZUCKER RATS", International journal of obesity, 21(2), 1997, pp. 115-121
92. YAMASAKI Y; KAWAMORI R; WASADA T; SATO A; OMORI Y; EGUCHI H; TOMINAGA M; SASAKI H; IKEDA M; KUBOTA M; ISHIDA Y; HOZUMI T; BABA S; UEHARA M; SHICHIRI M; KANEKO T
    PIOGLITAZONE (AD-4833) AMELIORATES INSULIN-RESISTANCE IN PATIENTS WITH NIDDM
    Tohoku Journal of Experimental Medicine
    
    Y. Yamasaki et al., "PIOGLITAZONE (AD-4833) AMELIORATES INSULIN-RESISTANCE IN PATIENTS WITH NIDDM", Tohoku Journal of Experimental Medicine, 183(3), 1997, pp. 173-183
93. WEINSTOCK RS; MURRAY FT; DIANI A; SANGANI GA; WACHOWSKI MB; MESSINA JL
    PIOGLITAZONE - IN-VITRO EFFECTS ON RAT HEPATOMA-CELLS AND IN-VIVO LIVER HYPERTROPHY IN KKA(Y) MICE
    Pharmacology
    
    R.S. Weinstock et al., "PIOGLITAZONE - IN-VITRO EFFECTS ON RAT HEPATOMA-CELLS AND IN-VIVO LIVER HYPERTROPHY IN KKA(Y) MICE", Pharmacology, 54(4), 1997, pp. 169-178
94. OAKES ND; CAMILLERI S; FURLER SM; CHISHOLM DJ; KRAEGEN EW
    THE INSULIN SENSITIZER, BRL-49653, REDUCES SYSTEMIC FATTY-ACID SUPPLYAND UTILIZATION AND TISSUE LIPID AVAILABILITY IN THE RAT
    Metabolism, clinical and experimental
    
    N.D. Oakes et al., "THE INSULIN SENSITIZER, BRL-49653, REDUCES SYSTEMIC FATTY-ACID SUPPLYAND UTILIZATION AND TISSUE LIPID AVAILABILITY IN THE RAT", Metabolism, clinical and experimental, 46(8), 1997, pp. 935-942
95. MORIMOTO Y; NISHIKAWA K; OHASHI M
    KB-R7785, A NOVEL MATRIX METALLOPROTEINASE INHIBITOR, EXERTS ITS ANTIDIABETIC EFFECT BY INHIBITING TUMOR-NECROSIS-FACTOR-ALPHA PRODUCTION
    Life sciences
    
    Y. Morimoto et al., "KB-R7785, A NOVEL MATRIX METALLOPROTEINASE INHIBITOR, EXERTS ITS ANTIDIABETIC EFFECT BY INHIBITING TUMOR-NECROSIS-FACTOR-ALPHA PRODUCTION", Life sciences, 61(8), 1997, pp. 795-803
96. UCHIDA A; NAKATA T; HATTA T; KIYAMA M; KAWA T; MORIMOTO S; MIKI S; MORIGUCHI J; NAKAMURA K; FUJITA H; ITOH H; SASAKI S; TAKEDA K; NAKAGAWA M
    REDUCTION OF INSULIN-RESISTANCE ATTENUATES THE DEVELOPMENT OF HYPERTENSION IN SUCROSE-FED SHR
    Life sciences
    
    A. Uchida et al., "REDUCTION OF INSULIN-RESISTANCE ATTENUATES THE DEVELOPMENT OF HYPERTENSION IN SUCROSE-FED SHR", Life sciences, 61(4), 1997, pp. 455-464
97. MARTIN G; SCHOONJANS K; LEFEBVRE AM; STAELS B; AUWERX J
    COORDINATE REGULATION OF THE EXPRESSION OF THE FATTY-ACID TRANSPORT PROTEIN AND ACYL-COA SYNTHETASE GENES BY PPAR-ALPHA AND PPAR-GAMMA ACTIVATORS
    The Journal of biological chemistry
    
    G. Martin et al., "COORDINATE REGULATION OF THE EXPRESSION OF THE FATTY-ACID TRANSPORT PROTEIN AND ACYL-COA SYNTHETASE GENES BY PPAR-ALPHA AND PPAR-GAMMA ACTIVATORS", The Journal of biological chemistry, 272(45), 1997, pp. 28210-28217
98. SUZUKI M; NOMURA C; ODAKA H; IKEDA H
    EFFECT OF AN INSULIN SENSITIZER, PIOGLITAZONE, ON HYPERTENSION IN FRUCTOSE-DRINKING RATS
    Japanese Journal of Pharmacology
    
    M. Suzuki et al., "EFFECT OF AN INSULIN SENSITIZER, PIOGLITAZONE, ON HYPERTENSION IN FRUCTOSE-DRINKING RATS", Japanese Journal of Pharmacology, 74(4), 1997, pp. 297-302
99. IGARASHI M; TAKEDA Y; ISHIBASHI N; TAKAHASHI K; MORI S; TOMINAGA M; SAITO Y
    PIOGLITAZONE REDUCES SMOOTH-MUSCLE CELL-DENSITY OF RAT CAROTID ARTERIAL INTIMA INDUCED BY BALLOON CATHETERIZATION
    Hormone and Metabolic Research
    
    M. Igarashi et al., "PIOGLITAZONE REDUCES SMOOTH-MUSCLE CELL-DENSITY OF RAT CAROTID ARTERIAL INTIMA INDUCED BY BALLOON CATHETERIZATION", Hormone and Metabolic Research, 29(9), 1997, pp. 444-449
100. GRAF K; XI XP; HSUEH WA; LAW RE
     TROGLITAZONE INHIBITS ANGIOTENSIN-II-INDUCED DNA-SYNTHESIS AND MIGRATION IN VASCULAR SMOOTH-MUSCLE CELLS
     FEBS letters
     
     K. Graf et al., "TROGLITAZONE INHIBITS ANGIOTENSIN-II-INDUCED DNA-SYNTHESIS AND MIGRATION IN VASCULAR SMOOTH-MUSCLE CELLS", FEBS letters, 400(1), 1997, pp. 119-121